日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SIAH2-WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer

SIAH2-WNK1信号通路驱动结直肠癌的糖酵解代谢和治疗耐药性

Kiu, Kee-Thai; Chu, Cheng-Ying; Cheng, Yi-Chiao; Yen, Min-Hsuan; Chen, Ying-Wei; Pikatan, Narpati Wesa; Yadav, Vijesh Kumar; Chang, Tung-Cheng

Metastatic breast cancer cells are vulnerable to fatty acid oxidation inhibition through DDX3-DRP1-mediated mitochondrial plasticity.

转移性乳腺癌细胞易受 DDX3-DRP1 介导的线粒体可塑性抑制的脂肪酸氧化作用的影响

Hsu Wen-Jing, Hsu Ming-Chien, Chu Cheng-Ying, Lee Yu-Cheng, Yang Ching-Chieh, Liu Zei-Wei, Lee Chi-Ching, Lin Yang-Sen, Lin Cheng-Wei

Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

更正:组胺N-甲基转移酶(HNMT)作为预测乳腺癌患者对HER2抑制剂药物治疗适应性的潜在辅助生物标志物

Cheng, Tzu-Chun; Hung, Mien-Chie; Wang, Lu-Hai; Tu, Shih-Hsin; Wu, Chih-Hsiung; Yen, Yun; Chen, Chi-Long; Whang-Peng, Jacqueline; Lee, Wen-Jui; Liao, You-Cheng; Lee, Yu-Ching; Pan, Min-Hsiung; Lin, Hui-Kuan; Tzeng, Huey-En; Guo, Peixuan; Chu, Cheng-Ying; Chen, Li-Ching; Ho, Yuan-Soon

Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer.

以SIAH1/2介导的泛素-蛋白酶体降解为靶点PPARγ作为管腔型膀胱癌的一种新治疗方法

Tu Chih-Chieh, Hsieh Tsung-Han, Chu Cheng-Ying, Lin Yu-Chen, Lin Bo-Jyun, Chen Chun-Han

Anatomical variations in 3D imaging: A case report of a dorsal metacarpal artery anomaly

三维成像中的解剖变异:一例背侧掌骨动脉异常的病例报告

Chen, Shin-Yun; Chen, Wei-Ta; Fong, Tsorng-Harn; Horng, Jiun-Lin; Chu, Cheng-Ying; Yang, Haojan; Yang, Tien-Chun

Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction

黄酮类化合物木犀草素和槲皮素通过抑制RPS19并降低c-Myc水平来促进癌细胞转移。

Chen, Ku-Chung; Hsu, Wen-Hsien; Ho, Jhih-Yun; Lin, Cheng-Wei; Chu, Cheng-Ying; Kandaswami, Chithan C; Lee, Ming-Ting; Cheng, Chia-Hsiung